Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05655091

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in…

This prospective randomized, controlled interventional pilot trial, aims to compare the achievement of the optimal target concentration with continuously admini…

Switzerland36 participantsStarted 2023-10-26

Treatment: FLU or CZO as continuous infusion, standard FLU or CZO intermittent bolus administration

All recent trials (2 shown)

CompletedNot Applicable

NCT04503252

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicat…

Given the paucity of pharmacological data on cefazolin treatment of Methicillin-susceptible S. aureus (MSSA) complicated S. aureus infection (CSAI), the primary…

Switzerland50 participantsStarted 2020-01-14

Treatment: Blood samples for the measurement of the concentration of cefazolin, S. aureus culture isolate